Mishima, Japan

Asako Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Toyo Jozo Company, Ltd.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asako Watanabe. Retrieved from https://idiyas.com/inventor/asako-watanabe-dgvob7gw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Asako Watanabe: Innovator in Antimicrobial Compounds

Introduction

Asako Watanabe is a prominent inventor based in Mishima, Japan. She has made significant contributions to the field of antimicrobial agents through her innovative research and development. Her work has led to the creation of unique compounds that have potential applications in medicine.

Latest Patents

Watanabe holds a patent for her invention titled "9-dihydro-9-O-alkyldesmycosin derivatives." This patent describes the derivatives and their salts, which are represented by a specific chemical formula. The compounds are noted for their effectiveness as antimicrobial agents, providing a high blood concentration when administered orally, unlike known desmycosin derivatives.

Career Highlights

Watanabe is associated with Toyo Jozo Company, Ltd., where she continues to advance her research in the field of pharmaceuticals. Her innovative approach has garnered attention in the scientific community, contributing to the development of new antimicrobial solutions.

Collaborations

Watanabe has collaborated with notable colleagues, including Tatsuro Fujiwara and Yuji Kogami. These partnerships have enhanced her research efforts and expanded the scope of her work in antimicrobial compounds.

Conclusion

Asako Watanabe's contributions to the field of antimicrobial agents highlight her role as a leading inventor. Her innovative compounds have the potential to make a significant impact in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…